Tags

Type your tag names separated by a space and hit enter

Comparison of Postoperative Smoking Cessation Rates of Patients with Benign or Premalignant Vocal Cord Lesions.
Sisli Etfal Hastan Tip Bul. 2018; 52(2):114-118.SE

Abstract

Objectives

It has been determined that cigarette is a risk factor for squamous cell carcinomas of the oral cavity, esophagus, and larynx. We aimed to investigate the role of histopathological diagnosis of the lesion in smoker patients with vocal cord lesion on smoking cessation rates and to determine strategies to help them quit smoking.

Methods

In this prospective clinical study, we included 182 (112 male, 70 female) smoker patients who underwent direct laryngoscopy and biopsy due to premalignant (dysplasia) or benign (polyp, leukoplasia, nodule) vocal cord lesions between July 2014 and December 2017 at our clinic. Smoking habits (ex-smoker, current smoker) of all smoker patients were questioned at least 6 months postoperatively, and postoperative smoking cessation rates were compared.

Results

When the smoking cessation rates of the patients with benign and premalignant vocal cord lesions were evaluated, the smoking cessation rate of the patients with premalignant vocal cord lesions was 3.45 times higher than that of the patients with benign vocal cord lesions (OR, 3.45; 95% CI, 1.76-6.74) (p<0.001). The postoperative application rate of the patients to smoking cessation outpatient clinics was low (6%). Male patients with premalignant lesions were more likely to quit smoking than female patients (p=0.001).

Conclusion

Patients with premalignant vocal cord lesions had higher smoking cessation rates. Premalignant vocal cord lesions require clinical follow-up and treatment because of the risk and potential for their transformation into in situ or invasive laryngeal carcinomas.

Authors+Show Affiliations

Department of Otorhinolaryngology Head and Neck Surgery, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.Department of Otorhinolaryngology Head and Neck Surgery, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.Department of Otorhinolaryngology Head and Neck Surgery, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.Department of Otorhinolaryngology Head and Neck Surgery, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.Department of Otorhinolaryngology Head and Neck Surgery, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.Department of Otorhinolaryngology Head and Neck Surgery, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32595383

Citation

Türk, Bilge, et al. "Comparison of Postoperative Smoking Cessation Rates of Patients With Benign or Premalignant Vocal Cord Lesions." Sisli Etfal Hastanesi Tip Bulteni, vol. 52, no. 2, 2018, pp. 114-118.
Türk B, Akpınar M, Dizdar SK, et al. Comparison of Postoperative Smoking Cessation Rates of Patients with Benign or Premalignant Vocal Cord Lesions. Sisli Etfal Hastan Tip Bul. 2018;52(2):114-118.
Türk, B., Akpınar, M., Dizdar, S. K., Kaya, K. S., Çoktur, A., & Coşkun, B. U. (2018). Comparison of Postoperative Smoking Cessation Rates of Patients with Benign or Premalignant Vocal Cord Lesions. Sisli Etfal Hastanesi Tip Bulteni, 52(2), 114-118. https://doi.org/10.14744/SEMB.2017.08760
Türk B, et al. Comparison of Postoperative Smoking Cessation Rates of Patients With Benign or Premalignant Vocal Cord Lesions. Sisli Etfal Hastan Tip Bul. 2018;52(2):114-118. PubMed PMID: 32595383.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Comparison of Postoperative Smoking Cessation Rates of Patients with Benign or Premalignant Vocal Cord Lesions. AU - Türk,Bilge, AU - Akpınar,Meltem, AU - Dizdar,Senem Kurt, AU - Kaya,Kerem Sami, AU - Çoktur,Alican, AU - Coşkun,Berna Uslu, Y1 - 2018/05/31/ PY - 2017/11/01/received PY - 2017/11/14/accepted PY - 2020/6/30/entrez PY - 2018/5/31/pubmed PY - 2018/5/31/medline KW - Cigarette KW - tobacco KW - vocal cord SP - 114 EP - 118 JF - Sisli Etfal Hastanesi tip bulteni JO - Sisli Etfal Hastan Tip Bul VL - 52 IS - 2 N2 - Objectives: It has been determined that cigarette is a risk factor for squamous cell carcinomas of the oral cavity, esophagus, and larynx. We aimed to investigate the role of histopathological diagnosis of the lesion in smoker patients with vocal cord lesion on smoking cessation rates and to determine strategies to help them quit smoking. Methods: In this prospective clinical study, we included 182 (112 male, 70 female) smoker patients who underwent direct laryngoscopy and biopsy due to premalignant (dysplasia) or benign (polyp, leukoplasia, nodule) vocal cord lesions between July 2014 and December 2017 at our clinic. Smoking habits (ex-smoker, current smoker) of all smoker patients were questioned at least 6 months postoperatively, and postoperative smoking cessation rates were compared. Results: When the smoking cessation rates of the patients with benign and premalignant vocal cord lesions were evaluated, the smoking cessation rate of the patients with premalignant vocal cord lesions was 3.45 times higher than that of the patients with benign vocal cord lesions (OR, 3.45; 95% CI, 1.76-6.74) (p<0.001). The postoperative application rate of the patients to smoking cessation outpatient clinics was low (6%). Male patients with premalignant lesions were more likely to quit smoking than female patients (p=0.001). Conclusion: Patients with premalignant vocal cord lesions had higher smoking cessation rates. Premalignant vocal cord lesions require clinical follow-up and treatment because of the risk and potential for their transformation into in situ or invasive laryngeal carcinomas. SN - 1302-7123 UR - https://www.unboundmedicine.com/medline/citation/32595383/Comparison_of_Postoperative_Smoking_Cessation_Rates_of_Patients_with_Benign_or_Premalignant_Vocal_Cord_Lesions L2 - https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32595383/ DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.